Retraction of: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1 (10.1089/dna.2018.4441)

Abstract

DNA and Cell BiologyVol. 41, No. 6 Retraction NoticeFree AccessRetraction of: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1 (10.1089/dna.2018.4441)This article retracts the following:Retracted: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1Published Online:10 Jun 2022https://doi.org/10.1089/dna.2018.4441.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Editor-in-Chief of DNA and Cell Biology officially retracts the article entitled, “miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1” by Su Y, Wang J, Ma Z, Gong W, Yu L. (DNA Cell Biol. 2019;38(2):144–150; 10.1089/dna.2018.4441) due to apparent duplication of images published in another journal1 and after receiving a report by the PRIMeR group out of the University of Sydney (Australia) led by Professor Jennifer Byrne, identifying that the ACTB forward and reverse primers provided under the section quantitative real-time PCR are primers targeting ACTB within Rattus rattus, not humans. Within the human transcriptome, they would be expected to also target two separate genes (forward: ACTG1, reverse: ACTC1). The Editor agrees with the report.The authors were contacted via email of the reported issues utilizing the email addresses provided to the journal at the time of submission in 2018, though no response was received.The Editor and Publisher of DNA and Cell Biology are committed to preserving the veracity of scientific literature and the community it serves.Reference1. Ono C, Fukuhara T, Motooka D, et al. Characterization of miR-122-independent propagation of HCV. PLoS Pathog. Epub May 11, 2017; https://doi.org/10.1371/journal.ppat.1006374 Google ScholarFiguresReferencesRelatedDetailsRelated articlesRetracted: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D16 Feb 2019DNA and Cell Biology Volume 41Issue 6Jun 2022 InformationCopyright 2022, Mary Ann Liebert, Inc., publishersTo cite this article:Retraction of: miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1 (10.1089/dna.2018.4441).DNA and Cell Biology.Jun 2022.641-641.http://doi.org/10.1089/dna.2018.4441.retractPublished in Volume: 41 Issue 6: June 10, 2022PDF download